Leishmania expressed lipophosphoglycan interacts with Toll-like receptor (TLR)-2 to decrease TLR-9 expression and reduce anti-leishmanial responses

Clin Exp Immunol. 2013 Jun;172(3):403-9. doi: 10.1111/cei.12074.

Abstract

Two different Toll-like receptors (TLRs) have been shown to play a role in host responses to Leishmania infection. TLR-2 is involved in parasite survival in macrophages upon activation by lipophosphoglycan (LPG), a virulence factor expressed by Leishmania. In contrast, activation of TLR-9 has been shown to promote a host-protective response. However, whether there is a relationship between the interaction of LPG and TLR-2, on one hand, with the effect of TLR-9, on the other hand, remains unknown. In this study, we report that in-vitro infection of macrophages with a L. major parasite with high expression levels of LPG results in decreased TLR-9 expression compared to infection with a L. major parasite with lower expression levels of LPG. Addition of anti-LPG as well as anti-TLR-2 antibodies prevents this reduction of TLR-9 expression. Also, the addition of purified LPG to macrophages results in a decrease of TLR-9 expression, which is shown to be mediated by transforming growth factor (TGF)-β and interleukin (IL)-10. Finally, in-vitro treatment of macrophages with anti-LPG and/or anti-TLR-2 antibodies before infection reduces the number of amastigotes in macrophages and co-treatment of mice with anti-TLR-2 antibodies and cytosine-phosphate-guanosine (CpG) reduces footpad swelling and parasite load in the draining lymph nodes, accompanied by an interferon (IFN)-γ-predominant T cell response. Thus, for the first time, we show how interactions between LPG and TLR-2 reduce anti-leishmanial responses via cytokine-mediated decrease of TLR-9 expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CpG Islands / immunology
  • Gene Expression
  • Glycosphingolipids / genetics
  • Glycosphingolipids / immunology*
  • Host-Parasite Interactions / genetics
  • Host-Parasite Interactions / immunology
  • Immune Tolerance
  • Interleukin-10 / genetics
  • Interleukin-10 / metabolism
  • Leishmania major / genetics
  • Leishmania major / immunology*
  • Leishmania major / pathogenicity*
  • Leishmaniasis, Cutaneous / genetics
  • Leishmaniasis, Cutaneous / immunology
  • Leishmaniasis, Cutaneous / parasitology
  • Leishmaniasis, Cutaneous / therapy
  • Macrophage Activation
  • Macrophages / immunology
  • Macrophages / parasitology
  • Mice
  • Mice, Inbred BALB C
  • Nitric Oxide Synthase Type II / genetics
  • Nitric Oxide Synthase Type II / metabolism
  • Toll-Like Receptor 2 / antagonists & inhibitors
  • Toll-Like Receptor 2 / genetics
  • Toll-Like Receptor 2 / metabolism*
  • Toll-Like Receptor 9 / genetics
  • Toll-Like Receptor 9 / metabolism*
  • Transforming Growth Factor beta / genetics
  • Transforming Growth Factor beta / metabolism
  • Virulence / immunology

Substances

  • Glycosphingolipids
  • IL10 protein, mouse
  • Tlr2 protein, mouse
  • Tlr9 protein, mouse
  • Toll-Like Receptor 2
  • Toll-Like Receptor 9
  • Transforming Growth Factor beta
  • lipophosphonoglycan
  • Interleukin-10
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse